Patient rights, access to treatment and the evidence behind prescribing will be discussed at a London event in November, with a separate Frankfurt symposium examining care in Germany. This story first appeared on leafie, view here Author: Liam O'Dowd
Canify’s Silvia von Pistor will join a discussion on medicine quality and what happens when patients need to switch products. Go to Source Author:
Pain specialist Dr Michael Überall discusses cannabinoid-based medicines, opioids, and what meaningful improvement looks like for patients. Go to Source Author:
Copyright © 2020 – 2026 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.